Related stories
WuXi Biologics and Fresenius Sign an Agreement
WuXi Biologics and Fresenius have signed an agreement.
M impact | EQUITY | Nov 03, 2026, 03:25 AM UTC
FWD Group Reports Nine-Month New Business CSM Up 22% to $1.4B
FWD Group reported unaudited nine-month new business contractual service margin of $1.4 billion, up 22% year over year. Value of new business was $878 million, up 18%, and new busi
M impact | EQUITY | Nov 03, 2026, 03:24 AM UTC
Taiwan Stocks Fall More Than 2% Intraday
Taiwan stocks extended losses to more than 2% intraday, Reuters reported, as the Philadelphia Semiconductor Index continued to fall and the U.S. struck Iran.
M impact | EQUITY | Nov 03, 2026, 03:23 AM UTC
Oracle Prices $1.5B Offering of 8.650% Notes Due 2046
M impact | EQUITY | Nov 03, 2026, 03:21 AM UTC
Oracle Expects About $10.0B in Net Proceeds From Note Offering
M impact | EQUITY | Nov 03, 2026, 03:21 AM UTC
Oracle Prices $2.5 Billion Notes Offering Due 2037
Oracle priced $2.5 billion of notes bearing 8.000% interest and due in 2037.
M impact | EQUITY | Nov 03, 2026, 03:21 AM UTC